TrialFrontiers in pharmacology2026

The role of sitagliptin in modifying metabolic, hormonal and clinical parameters in polycystic ovarian syndrome patients: a randomized controlled trial.

Ahmed E Altyar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.